|
|
|
| Abstracts Submission | Read before submitting | |||
And send it by E-Mail to: info@enasymposium2008.org By submitting, you declare that the work described in this abstract has appropriate approval under local, ethical and animal experimentation rules. If your abstract is accepted for presentation at the Congress, you also accept that the abstract be published in an University of Granada's journals and might be made available on the ENA website (www.enasymposium2008.org). If the abstract is accepted as a poster, you therefore agree to present the abstract at the Congress. Scientific Secretariat Dept. of Paediatrics School of Medicine University of Granada Avda. de Madrid, 11 18012 Granada Fax: (+34) 958240740 E-mail: info@enasymposium2008.org Technical Secretariat VIAJES EL CORTE INGLÉS - DIVISIÓN CONGRESOS C/ San Antón, 67, 1º A - 18005 Granada Phone: +34 - 958 536820 // +34 - 958 536821 Fax: +34 958 254892 E-mail: earnestsymposium@viajeseci.es |
ABSTRACT TYPING INSTRUCTIONS:
Available space must be used as follows and contain the following sections: • Rationale • Methods • Results • Conclusions The abstract cannot contain more than 2500 characters. Please note that spaces, punctuation and special characters count within the 2500 allowed characters. Author's details are not included. All abstracts will be printed in the Abstract Book of the International Symposium General remarks: 1. Abstracts must contain data and meet international ethical standards. 2. Abbreviations should be defined. 3. The Rationale section should contain 1-2 sentences that clearly indicate the scientific question of the study and its clinical (or other) importance. 4. The Methods section should contain sufficient information to be able to understand the experimental design, the analytical techniques and the statistics used in the study. 5. The Results section should contain objective data to answer the scientific question. 6. The Conclusions section should provide only conclusions of the study directly supported by the results, along with implications for clinical practice, avoiding speculation and overgeneralization. 7. Trade names can not be mentioned in the title. However, trade names in brackets will be accepted in the body of the text. 8. Linguistic accuracy is your responsibility. |
Disclosure of Interest
The intent of ENA is to provide high-quality sessions focused on educational content that is free from commercial influence or bias. We request all presenters to cooperate in this by: 1. Declaring any potential conflict of interest. 2. Declaring any commercial role. The intent of this disclosure is not to prevent an author with a conflict of interest from making a presentation but to make known the relationship, in advance, to the audience. It is intended that any commercial affiliation be openly identified so that, with the full disclosure of the facts, the attendees may form their own judgements about the presentation. Please mention in your E-Mail "None declared" if there is no conflict of interest to declare. Otherwise please, list companies and the type of disclosure for every author in alphabetical order, separated by commas. Please choose the type of disclosure from the following list: Grant/Research Support Consultant Speakers Bureau Shareholder Paid instructor Other (please explain) For example: J.Smith, Company A, Grant Research Support M.Brown, Company B, Consultant J.Doe, Company B, Speakers Bureau J.Doe, Company C, Grant Research Support etc.. |
||
 |
